세계의 십이지장 궤양 치료 시장 - 규모, 점유율, 동향 분석 보고서 : 치료별, 투여 경로별, 유통 경로별, 지역별, 부문별 예측(2025-2030년)

Duodenal Ulcer Treatment Market Size, Share & Trends Analysis Report By Treatment (Proton Pump Inhibitors, H2 Antagonists), By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,839,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,325,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 13,297,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

십이지장 궤양 치료 시장의 성장과 동향

세계 십이지장 궤양 치료 시장 규모는 2030년에는 55억 4,000만 달러에 달할 것으로 예측되며, 2025-2030년 동안 CAGR은 3.2%로 성장할 것으로 예측됩니다. 이 시장에는 십이지장 궤양(십이지장의 내벽에서 발생하는 궤양)의 관리와 치료에 초점을 맞춘 다양한 요소가 포함되어 있습니다.

약리학 치료는 십이지장 궤양 치료 시장에 매우 중요합니다. 이러한 약물에는 양성자 펌프 억제제(PPI), 히스타민 수용체 길항제(H2RA), 헬리코박터 파일로리 감염을 표적으로하는 항생제, 점막 보호제, 제산제 등이 포함됩니다. 이러한 약물은 위산의 분비를 억제하고, 세균성 병원체를 제거하고, 점막 방어를 강화하고, 위산을 중화합니다. 이 치료 방법은 궤양의 치유를 촉진하는 반면 복부 팽만감, 복통, 불편함을 완화합니다.

이 시장은 모바일 앱, 원격 의료 플랫폼, 원격 모니터링 툴 등의 디지털 헬스 솔루션의 도입으로 큰 성장을 이루고 있습니다. 이러한 기술은 맞춤 치료 관리, 실시간 증상 추적, 환자 참여의 강화를 가능하게 합니다. 또한 인공지능(AI) 알고리즘이 대규모 데이터세트 분석에 채택되어 치료 성적 향상과 궤양 문제의 조기 발견을 촉진하고 있습니다.

십이지장 궤양 치료 시장 보고서 하이라이트

• 양성자 펌프 억제제 부문은 특히 십이지장 궤양과 같은 질병에 걸리기 쉬운 노인층에서 위장 질환의 유병률이 증가함에 따라 2024년 매출 점유율 52.1%로 시장을 독점했습니다.
• 경구 부문은 투여하기 쉽고 편리한 비침습 치료 옵션에 대한 환자 선호도가 시장을 견인하여 2024년 최대 판매 점유율을 얻었습니다.
• 소매 약국 부문은 십이지장 궤양의 시판약을 요구하는 환자에게 소매 약국이 제공하는 접근성과 편의성으로 2024년 최대의 수익 점유율을 차지했습니다.
• 북미의 십이지장 궤양 치료 시장은 2024년에 39.5%의 최고 수익 점유율을 차지했는데, 이는 첨단 의료 인프라와 소비자의 고수준 의료비에 힘입은 것이었습니다.
• 병원 약국 부문은 예측 기간 동안 CAGR로 크게 성장할 것으로 예측됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 십이지장 궤양 치료 시장의 변수, 동향, 범위

• 시장 계통의 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • 산업 분석 - Porter's Five Forces 분석
  • PESTLE 분석

제4장 십이지장 궤양 치료 시장 : 치료 비즈니스 분석

• 치료 시장 점유율, 2024년과 2030년
• 치료 부문 대시보드
• 시장 규모와 예측과 동향 분석, 치료별, 2018-2030년
• 양성자 펌프 억제제
• H2 길항제
• 항생제
• 기타

제5장 십이지장 궤양 치료 시장 : 투여 경로 비즈니스 분석

• 투여 경로 시장 점유율, 2024년과 2030년
• 투여 경로 부문 대시보드
• 시장 규모와 예측과 동향 분석, 투여 경로별, 2018-2030년
• 경구
• 비경구

제6장 십이지장 궤양 치료 시장 : 유통 채널 비즈니스 분석

• 유통 채널 시장 점유율, 2024년과 2030년
• 유통 채널 부문 대시보드
• 시장 규모와 예측과 동향 분석, 유통 채널별, 2018-2030년
• 병원 약국
• 소매 약국
• 기타

제7장 십이지장 궤양 치료 시장 : 지역별, 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년과 2030년
• 지역별 시장 대시보드
• 시장 규모와 예측 동향 분석, 2018-2030년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 참가자 개요
• 기업의 시장 포지셔닝 분석
• 기업 분류
• 전략 매핑
• 기업 프로파일/상장 기업
  • GSK plc.
  • Pfizer Inc.
  • Novartis AG
  • Merck KGaA
  • NIHON GENERIC Co., Ltd.
  • Abbott
  • AstraZeneca
  • Bristol-Myers Squibb Company
  • Takeda Pharmaceutical Company Limited.
  • Eisai Co., Ltd.

JHS

영문 목차

영문목차

Duodenal Ulcer Treatment Market Growth & Trends:

The global duodenal ulcer treatment market size is anticipated to reach USD 5.54 billion in 2030 and is anticipated to grow at a CAGR of 3.2% from 2025 to 2030. The market encompasses a range of elements focused on the management and treatment of duodenal ulcers, which are sores that occur in the lining of the duodenum.

Pharmacological treatments are crucial to the duodenal ulcer treatment market. These medications include proton pump inhibitors (PPIs), histamine receptor antagonists (H2RAs), and antibiotics targeting Helicobacter pylori infections, mucosal protectants, and antacids. These medications reduce gastric acid production, eradicate bacterial pathogens, enhance mucosal defense, or neutralize stomach acid. This therapeutic approach alleviates bloating, abdominal pain, and discomfort while accelerating ulcer healing.

The market is experiencing significant growth due to the incorporation of digital health solutions such as mobile apps, telemedicine platforms, and remote monitoring tools. These technologies enable personalized treatment management, real-time symptom tracking, and enhanced patient engagement. Additionally, artificial intelligence (AI) algorithms are being employed to analyze large datasets, which improves treatment outcomes and facilitates early detection of ulcer issues.

Duodenal Ulcer Treatment Market Report Highlights:

• The proton pump inhibitors segment dominated the market with a revenue share of 52.1% in 2024, driven by the increasing prevalence of gastrointestinal disorders, particularly among the aging population, who are more susceptible to conditions such as duodenal ulcers
• The oral segment dominated the market with the largest revenue share in 2024, driven by patient preference for non-invasive treatment options that offer ease of administration and convenience
• The retail pharmacies segment dominated the market with the largest revenue share in 2024, fueled by the accessibility and convenience that retail pharmacies provide for patients seeking over-the-counter medications for duodenal ulcers
• North America duodenal ulcer treatment market held the highest revenue share of 39.5% in 2024, fueled by the advanced healthcare infrastructure and high levels of healthcare spending among consumers
• The hospital pharmacies segment is projected to grow at the significant CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Treatment
  • 1.2.2. Route of Administration
  • 1.2.3. Distribution Channel
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Duodenal Ulcer Treatment Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Duodenal Ulcer Treatment Market: Treatment Business Analysis

• 4.1. Treatment Market Share, 2024 & 2030
• 4.2. Treatment Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Billion)
• 4.4. Proton Pump Inhibitors
  • 4.4.1. Proton Pump Inhibitors Market, 2018 - 2030 (USD Billion)
• 4.5. H2 Antagonists
  • 4.5.1. H2 Antagonists Market, 2018 - 2030 (USD Billion)
• 4.6. Antibiotics
  • 4.6.1. Antibiotics Market, 2018 - 2030 (USD Billion)
• 4.7. Other
  • 4.7.1. Other Market, 2018 - 2030 (USD Billion)

Chapter 5. Duodenal Ulcer Treatment Market: Route of Administration Business Analysis

• 5.1. Route of Administration Market Share, 2024 & 2030
• 5.2. Route of Administration Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Billion)
• 5.4. Oral
  • 5.4.1. Oral Market, 2018 - 2030 (USD Billion)
• 5.5. Parenteral
  • 5.5.1. Parenteral Market, 2018 - 2030 (USD Billion)

Chapter 6. Duodenal Ulcer Treatment Market: Distribution Channel Business Analysis

• 6.1. Distribution Channel Market Share, 2024 & 2030
• 6.2. Distribution Channel Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Billion)
• 6.4. Hospital Pharmacies
  • 6.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Billion)
• 6.5. Retail Pharmacies
  • 6.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Billion)
• 6.6. Other
  • 6.6.1. Other Market, 2018 - 2030 (USD Billion)

Chapter 7. Duodenal Ulcer Treatment Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. North America Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework
    • 7.4.2.3. Competitive Insights
    • 7.4.2.4. U.S. Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework
    • 7.4.3.3. Competitive Insights
    • 7.4.3.4. Canada Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Regulatory Framework
    • 7.4.4.3. Competitive Insights
    • 7.4.4.4. Mexico Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 7.5. Europe
  • 7.5.1. Europe Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Insights
    • 7.5.2.4. UK Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Insights
    • 7.5.3.4. Germany Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Insights
    • 7.5.4.4. France Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework
    • 7.5.5.3. Competitive Insights
    • 7.5.5.4. Italy Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework
    • 7.5.6.3. Competitive Insights
    • 7.5.6.4. Spain Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.7. Denmark
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework
    • 7.5.7.3. Competitive Insights
    • 7.5.7.4. Denmark Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.8. Sweden
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework
    • 7.5.8.3. Competitive Insights
    • 7.5.8.4. Sweden Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.9. Norway
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Regulatory Framework
    • 7.5.9.3. Competitive Insights
    • 7.5.9.4. Norway Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Insights
    • 7.6.2.4. Japan Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Insights
    • 7.6.3.4. China Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Insights
    • 7.6.4.4. India Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Insights
    • 7.6.5.4. South Korea Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Insights
    • 7.6.6.4. Australia Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Insights
    • 7.6.7.4. Thailand Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 7.7. Latin America
  • 7.7.1. Latin America Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Insights
    • 7.7.2.4. Brazil Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Insights
    • 7.7.3.4. Argentina Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 7.8. MEA
  • 7.8.1. MEA Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Insights
    • 7.8.2.4. South Africa Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework
    • 7.8.3.3. Competitive Insights
    • 7.8.3.4. Saudi Arabia Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework
    • 7.8.4.3. Competitive Insights
    • 7.8.4.4. UAE Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Framework
    • 7.8.5.3. Competitive Insights
    • 7.8.5.4. Kuwait Duodenal Ulcer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. GSK plc.
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Product Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. Pfizer Inc.
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Product Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. Novartis AG
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Product Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. Merck KGaA
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Product Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. NIHON GENERIC Co., Ltd.
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Product Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. Abbott
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Product Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. AstraZeneca
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic Initiatives
  • 8.5.8. Bristol-Myers Squibb Company
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial Performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic Initiatives
  • 8.5.9. Takeda Pharmaceutical Company Limited.
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial Performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic Initiatives
  • 8.5.10. Eisai Co., Ltd.
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial Performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic Initiatives

관련자료